Form 1 2020 Trans-NCI-NIH Conference Survey

OMB No.: 0925-0642

Expiration Date: 5/31/2020

Public reporting burden for this collection of information is estimated to average 8 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0642). Do not return the completed form to this address.

Thank you for your participation in the Trans-NCI-NIH Conference on International Perspectives on Integrative Medicine for Cancer Prevention and Cancer Patient Management. The organizing committee would like to get an understanding if we achieved our aims and ideas for improvements for the future. The two main aims of the conference are: to 1) discuss the integration of traditional, complementary and alternative medicine (TCAM) with conventional cancer prevention and treatment approaches in global health and particularly in low-and-middle-income-countries (LMICs) thus forming new approaches to Integrative Oncology, and 2) discuss concrete approaches for strengthening Integrative Oncology research in LMICs.

This survey should take approximately 8 minutes of your time.

Thanks for your collaboration. Conference Organizing Committee

1. What is your level of experience?

U ndergraduate Student Graduate or Medical Student Post-doc or Resident

Junior-level Faculty/Professional Mid-level Faculty/Professional Senior-level Faculty/Professional

2. What field do you work in (e.g. integrative oncology, public health, clinical research, etc.)?

3. What is your specific area of work and/or interest (e.g. cervical cancer, pediatric oncology, communications and advocacy, etc.)?

4. To what extent do you agree or disagree with the following statements about your overall experience at the Conference?

Completely Agree Agree Disagree Completely Disagree

I was satisfied with the content of the conference

T he conference content was useful to my work/interests

M y knowledge on global integrative oncology practices and research-related particularly in LMICs was advanced or complemented by the conference

T he conference provided an opportunity for information exchange among participants

I was able to learn about various current partnerships and to make connections with other participants

5. What was most valuable about the Conference

6. For each of the following Conference sessions, please rate their usefulness to you as a participant and provide any feedback for improvement of the session, including comments on content and/or format (selection options will be Very Useful, Moderately Useful, Slightly Useful, Not Useful and Did not Attend).

Completely Agree Agree Disagree Completely Disagree

K eynote Session: Challenges of cancer prevention, therapy and survivorship in LMICs and gaps that integrative oncology research could address by Dr. Partha Basu, International Agency of Research on Cancer (IARC)

P anel: The role of integrative cancer therapy, cancer prevention and cancer patient management in global health

P anel: Challenges and clashes of worldviews and circles of influence of western and traditional medical systems

P anel: Understanding the pharmacology of traditional medicine I was able to learn about various current partnerships and to make connections with other participants

R egional Presentations from China, India and Brazil:

I ntegration of Traditional Chines Medicine with Western medicine for cancer treatment and prevention and related research

I ntegration of Ayurveda with Western medicine for cancer treatment and prevention and related research

B razil and Latin America approaches to integrative oncology and related research

P anel: Research and evidence-based integrative oncology for cancer prevention and treatment

S ession on Examples Partnerships to enhance integrative oncology research in LMICs

Oral Poster Presentations Session

P anel Discussion: Potential mechanisms for strengthening integrative oncology research in LMICs

7. To what extent do you believe that the Conference was able to achieve the following objectives?

Completely Achieved Partially Achieved Marginally Achieved Not at all Achieved

P rovide a comprehensive overview of the role of integrative oncology research in addressing local, regional and global challenges in cancer prevention and treatment particularly in LMICs

P rovide a stimulating and engaging forum for knowledge sharing

P roduce an environment that facilitates the enhancement of current and potential new collaborations on Integrative Medicine to advance our knowledge and practice aimed at enhancing prevention and cancer patient management in LMICs

8.To what extent were you satisfied with the following elements of the Conference organization and format?

Very Satisfied Somewhat Satisfied Neutral Not Satisfied N/A

C larity of meeting objectives

O nline registration process

C heck-in on the day of the Symposium

Symposium venue

Q uality of material circulated by the organizers

O rganization of the agenda

Quality of presentations

A bstract Submission Process (if applicable)

9. Please use the space below to provide any recommendations to improve the organization and/or format of the Conference.

10. Please use the space below to indicate any additional discussion or items that you would like as next steps and/or addressed in the future